Y. Nagai

Characteristics and risk factors of an emergency department visit in patients with systemic lupus erythematosus

K. Shimada, S. Sugii, Y. Nagai, 2019, Rheumatology International.

Utility of the neutrophil-to-lymphocyte ratio for predicting bacterial infection in patients with rheumatoid arthritis receiving Tocilizumab

K. Shimada, S. Sugii, Y. Nagai, 2020, Rheumatology International.

Comparison of the clinical characteristics and severity of community-acquired pneumonia between patients with rheumatoid arthritis treated with tocilizumab and those treated with TNF inhibitor

K. Shimada, S. Sugii, Y. Nagai, 2018, Modern rheumatology.

Severe Thrombocytopenia Induced by First Infliximab Administration for Rheumatoid Arthritis.

K. Shimada, S. Sugii, Y. Nagai, 2016, American journal of therapeutics.

Validation of RAPID3 using a Japanese version of Multidimensional Health Assessment Questionnaire with Japanese rheumatoid arthritis patients: Characteristics of RAPID3 compared to DAS28 and CDAI

T. Kaneko, K. Shimada, T. Sawaki, 2015, Modern rheumatology.

Experience of 101 patients with coronavirus infectious disease 2019 (COVID-19) at a tertiary care center in Japan

K. Cho, H. Honda, S. Sakurai, 2020, Journal of Infection and Chemotherapy.